Insider Trading activities of Alnylam Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alnylam Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alnylam Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Alnylam Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is ALNY. The reporting company's CIK number is 1178670.
The total value of stock buying since 2005 is $34,133,539.
The total value of stock sales since 2005 is $113,055,473.
The total value of stock option exercises since 2005 is $9,096,099.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Alnylam Pharmaceuticals, Inc. (ALNY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2014-08 0 $0 13,500 $908,793 13,500 $109,619
2014-06 0 $0 124,293 $8,222,933 124,293 $939,548
2014-05 0 $0 162,168 $9,159,911 162,168 $1,340,090
2014-04 0 $0 0 $0 28,707 $546,294
2014-03 344,448 $23,036,682 32,769 $2,431,230 32,769 $315,401
2014-02 0 $0 24,150 $1,932,871 79,331 $602,191
2014-01 0 $0 22,890 $1,959,705 15,000 $237,300
2013-12 0 $0 60,230 $3,725,153 75,182 $797,164
2013-11 0 $0 13,500 $720,306 13,500 $215,865
2013-10 0 $0 15,000 $900,000 27,665 $225,368
2013-09 0 $0 65,197 $3,677,272 65,197 $114,124
2013-08 0 $0 60,000 $2,935,140 60,000 $57,000
2013-07 0 $0 101,200 $3,800,840 101,200 $1,098,088
2013-06 0 $0 38,625 $1,175,782 38,625 $415,518
2013-05 0 $0 27,822 $834,660 27,822 $57,180
2013-03 0 $0 106,939 $2,577,275 106,939 $153,779
2013-02 0 $0 63,503 $1,498,916 5,000 $35,500
2013-01 4,967 $99,985 0 $0 0 $0
2012-12 0 $0 17,177 $312,105 35,794 $151,999
2012-11 0 $0 6,573 $111,544 6,573 $46,668
2012-09 0 $0 1,558,146 $30,256,570 6,250 $58,124
2012-07 0 $0 57,795 $1,096,707 57,795 $573,083
2012-02 120,696 $1,297,480 0 $0 0 $0
2012-01 1,701 $14,986 0 $0 0 $0
2011-12 2,096 $14,990 0 $0 0 $0
2011-11 2,115 $14,990 0 $0 0 $0
2011-10 2,222 $14,983 0 $0 0 $0
2010-08 0 $0 0 $0 50,000 $23,750
2010-06 0 $0 85,000 $1,343,277 75,000 $526,499
2010-04 55,223 $993,461 0 $0 0 $0
2009-09 0 $0 75,000 $1,657,703 0 $0
2009-06 0 $0 120,000 $2,582,280 120,000 $57,000
2009-05 65,922 $1,153,635 0 $0 0 $0
2009-04 0 $0 25,000 $440,725 25,000 $23,750
2008-08 0 $0 110,440 $3,758,859 106,639 $65,324
2008-06 0 $0 0 $0 3,000 $1,425
2008-05 213,888 $5,409,227 0 $0 0 $0
2007-12 0 $0 18,778 $607,426 0 $0
2007-11 0 $0 37,222 $1,245,187 20,000 $218,200
2007-10 0 $0 103,590 $3,239,122 20,000 $19,000
2007-06 0 $0 113,847 $1,803,855 75,000 $35,624
2006-10 0 $0 12,500 $258,875 0 $0
2006-05 0 $0 112,583 $1,712,692 75,000 $35,624
2006-03 0 $0 400,882 $6,667,406 0 $0
2006-02 0 $0 616,049 $9,500,353 0 $0
2006-01 100,000 $1,300,000 0 $0 0 $0
2004-05 130,520 $783,120 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Alnylam Pharmaceuticals, Inc. insiders (ALNY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-08-18 Reid Laurence (SVP, Chief Business Officer) Sale 13,500 67.32 908,793
2014-08-18 Reid Laurence (SVP, Chief Business Officer) Option Ex 13,500 8.12 109,619
2014-06-26 Maraganore John (Chief Executive Officer) Sale 56,834 65.59 3,727,628
2014-06-26 Maraganore John (Chief Executive Officer) Option Ex 56,834 7.47 424,549
2014-06-25 Maraganore John (Chief Executive Officer) Sale 56,834 66.08 3,755,306
2014-06-25 Maraganore John (Chief Executive Officer) Option Ex 56,834 7.47 424,549
2014-06-17 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 10,625 69.65 739,999
2014-06-17 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 10,625 8.51 90,450
2014-05-21 Clarke John K (Director) Sale 35,000 54.71 1,914,745
2014-05-21 Clarke John K (Director) Option Ex 35,000 12.58 440,195
2014-05-19 Reid Laurence (SVP, Chief Business Officer) Sale 13,500 57.54 776,776
2014-05-19 Reid Laurence (SVP, Chief Business Officer) Option Ex 13,500 8.12 109,619
2014-05-15 Maraganore John (Chief Executive Officer) Sale 56,834 56.39 3,204,755
2014-05-15 Maraganore John (Chief Executive Officer) Option Ex 56,834 7.12 404,942
2014-05-14 Maraganore John (Chief Executive Officer) Sale 56,834 57.42 3,263,635
2014-05-14 Maraganore John (Chief Executive Officer) Option Ex 56,834 6.78 385,334
2014-04-14 Maraganore John (CEO) Option Ex 28,707 19.03 546,294
2014-03-25 Sanofi (10% Owner) Buy 344,448 66.88 23,036,682
2014-03-18 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 32,769 74.19 2,431,230
2014-03-18 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 32,769 9.62 315,401
2014-02-19 Reid Laurence (SVP, Chief Business Officer) Sale 20,400 80.24 1,636,794
2014-02-19 Reid Laurence (SVP, Chief Business Officer) Option Ex 13,500 11.54 155,857
2014-02-03 Mason Michael (VP, Finance and Treasurer) Sale 3,750 78.95 296,077
2014-02-03 Greene Barry E (President and COO) Option Ex 19,500 6.78 132,210
2014-02-03 Maraganore John (CEO) Option Ex 46,331 6.78 314,124
2014-01-24 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 7,890 86.10 679,305
2014-01-13 Schimmel Paul (Director) Sale 15,000 85.36 1,280,400
2014-01-13 Schimmel Paul (Director) Option Ex 15,000 15.82 237,300
2013-12-30 Reid Laurence (SVP, Chief Business Officer) Option Ex 3,752 15.99 59,994
2013-12-20 Schimmel Paul (Director) Sale 15,000 65.00 975,000
2013-12-20 Schimmel Paul (Director) Option Ex 15,000 11.33 169,950
2013-12-17 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 18,480 60.99 1,127,169
2013-12-17 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 18,480 12.96 239,500
2013-12-17 Greene Barry E (President and COO) Option Ex 11,200 6.78 75,936
2013-12-16 Mason Michael (VP, Finance and Treasurer) Sale 8,000 60.49 483,888
2013-12-16 Mason Michael (VP, Finance and Treasurer) Option Ex 8,000 12.18 97,464
2013-12-16 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 15,000 60.48 907,215
2013-12-16 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 15,000 8.51 127,695
2013-12-02 Mason Michael (VP, Finance and Treasurer) Sale 3,750 61.84 231,881
2013-12-02 Mason Michael (VP, Finance and Treasurer) Option Ex 3,750 7.10 26,625
2013-11-13 Reid Laurence (SVP, Chief Business Officer) Sale 13,500 53.36 720,306
2013-11-13 Reid Laurence (SVP, Chief Business Officer) Option Ex 13,500 15.99 215,865
2013-10-22 Schimmel Paul (Director) Sale 15,000 60.00 900,000
2013-10-22 Schimmel Paul (Director) Option Ex 15,000 9.30 139,500
2013-10-10 Maraganore John (Chief Executive Officer) Option Ex 12,665 6.78 85,868
2013-09-11 Maraganore John (Chief Executive Officer) Sale 58,947 56.26 3,316,122
2013-09-11 Maraganore John (Chief Executive Officer) Option Ex 58,947 .95 55,999
2013-09-10 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 6,250 57.78 361,150
2013-09-10 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 6,250 9.30 58,125
2013-08-14 Maraganore John (Chief Executive Officer) Sale 60,000 48.92 2,935,140
2013-08-14 Maraganore John (Chief Executive Officer) Option Ex 60,000 .95 57,000
2013-07-12 Mason Michael (VP, Finance & Treasurer) Sale 14,200 50.00 710,000
2013-07-12 Mason Michael (VP, Finance & Treasurer) Option Ex 14,200 31.39 445,738
2013-07-10 Maraganore John (Chief Executive Officer) Sale 60,000 37.11 2,226,840
2013-07-10 Maraganore John (Chief Executive Officer) Option Ex 60,000 .95 57,000
2013-07-01 Mason Michael (VP, Finance and Treasurer) Sale 27,000 32.00 864,000
2013-07-01 Mason Michael (VP, Finance and Treasurer) Option Ex 27,000 22.05 595,350
2013-06-17 Mason Michael (VP, Finance and Treasurer) Sale 23,625 29.93 707,167
2013-06-17 Mason Michael (VP, Finance and Treasurer) Option Ex 23,625 12.18 287,823
2013-06-11 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 15,000 31.24 468,615
2013-06-11 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 15,000 8.51 127,695
2013-05-28 Reid Laurence (SVP and Chief Business Officer) Sale 5,000 30.00 150,000
2013-05-28 Reid Laurence (SVP and Chief Business Officer) Option Ex 5,000 7.10 35,500
2013-05-28 Greene Barry E (President and COO) Sale 22,822 30.00 684,660
2013-05-28 Greene Barry E (President and COO) Option Ex 22,822 .95 21,680
2013-03-26 Starr Kevin P (Director) Sale 26,000 23.41 608,582
2013-03-26 Starr Kevin P (Director) Option Ex 26,000 .95 24,700
2013-03-25 Starr Kevin P (Director) Sale 26,631 23.56 627,559
2013-03-25 Starr Kevin P (Director) Option Ex 26,631 .95 25,299
2013-03-14 Greene Barry E (President & COO) Sale 24,058 25.00 601,450
2013-03-14 Greene Barry E (President & COO) Option Ex 24,058 .95 22,855
2013-03-11 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 6,250 24.55 153,412
2013-03-11 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 6,250 9.30 58,125
2013-03-08 Greene Barry E (President and COO) Sale 24,000 24.43 586,272
2013-03-08 Greene Barry E (President and COO) Option Ex 24,000 .95 22,800
2013-02-28 Maraganore John (Chief Executive Officer) Sale 28,503 23.50 669,906
2013-02-27 Maraganore John (Chief Executive Officer) Sale 30,000 23.47 704,010
2013-02-08 Reid Laurence (SVP, Chief Business Officer) Sale 5,000 25.00 125,000
2013-02-08 Reid Laurence (SVP, Chief Business Officer) Option Ex 5,000 7.10 35,500
2013-01-22 Sharp Philip A (Director) Buy 4,967 20.13 99,985
2012-12-19 Maraganore John (CEO) Option Ex 18,617 .48 8,843
2012-12-12 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 10,000 19.00 190,000
2012-12-12 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 10,000 9.22 92,200
2012-12-10 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 4,777 17.00 81,209
2012-12-10 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 4,777 7.10 33,916
2012-12-04 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 2,400 17.04 40,896
2012-12-04 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 2,400 7.10 17,040
2012-11-30 Mason Michael (VP, Finance and Treasurer) Sale 3,750 16.93 63,472
2012-11-30 Mason Michael (VP, Finance and Treasurer) Option Ex 3,750 7.10 26,625
2012-11-30 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 2,823 17.03 48,072
2012-11-30 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 2,823 7.10 20,043
2012-09-20 Novartis Pharma Ag (10% Owner) Sale 1,551,896 19.42 30,137,820
2012-09-12 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 4,916 19.00 93,404
2012-09-12 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 4,916 9.30 45,718
2012-09-10 Vaishnaw Akshay (EVP, Chief Medical Officer) Sale 1,334 19.00 25,346
2012-09-10 Vaishnaw Akshay (EVP, Chief Medical Officer) Option Ex 1,334 9.30 12,406
2012-07-27 Mason Michael (VP, Finance and Treasurer) Sale 6,250 20.00 125,000
2012-07-27 Mason Michael (VP, Finance and Treasurer) Option Ex 6,250 10.98 68,625
2012-07-16 Mason Michael (VP, Finance & Treasurer) Sale 15,295 18.50 282,957
2012-07-16 Mason Michael (VP, Finance & Treasurer) Option Ex 15,295 11.13 170,233
2012-07-16 Vaishnaw Akshay (SVP, Chief Medical Officer) Sale 36,250 19.00 688,750
2012-07-16 Vaishnaw Akshay (SVP, Chief Medical Officer) Option Ex 36,250 9.22 334,225
2012-02-21 Reid Laurence (SVP, Chief Business Officer) Buy 930 10.75 9,997
2012-02-21 Fanucci Marsha (Director) Buy 10,000 10.75 107,500
2012-02-21 Greene Barry E (President and COO) Buy 1,860 10.75 19,995
2012-02-21 Schimmel Paul (Director) Buy 93,023 10.75 999,997
2012-02-21 Sharp Philip A (Director) Buy 9,302 10.75 99,996
2012-02-21 Maraganore John (CEO) Buy 5,581 10.75 59,995
2012-01-09 Greene Barry E (President and COO) Buy 567 8.80 4,991
2012-01-09 Maraganore John (CEO) Buy 1,134 8.81 9,995
2011-12-12 Greene Barry E (President and COO) Buy 699 7.15 4,995
2011-12-12 Maraganore John (CEO) Buy 1,397 7.16 9,995
2011-11-14 Greene Barry E (President and COO) Buy 704 7.09 4,994
2011-11-14 Maraganore John (CEO) Buy 1,411 7.08 9,996
2011-10-11 Greene Barry E (President and COO) Buy 742 6.73 4,995
2011-10-11 Maraganore John (CEO) Buy 1,480 6.75 9,988
2010-08-17 Maraganore John (CEO) Option Ex 50,000 .48 23,750
2010-06-18 Vincent James L (Director) Sale 20,767 15.18 315,159
2010-06-18 Vincent James L (Director) Option Ex 12,100 7.02 84,942
2010-06-17 Vincent James L (Director) Sale 1,333 15.70 20,929
2010-06-15 Vincent James L (Director) Sale 30,000 16.00 480,090
2010-06-15 Vincent James L (Director) Option Ex 30,000 7.02 210,600
2010-06-14 Vincent James L (Director) Sale 17,900 16.08 287,849
2010-06-14 Vincent James L (Director) Option Ex 17,900 7.02 125,657
2010-06-11 Vincent James L (Director) Sale 15,000 15.95 239,250
2010-06-11 Vincent James L (Director) Option Ex 15,000 7.02 105,300
2010-04-23 Novartis Pharma Ag (10% Owner) Buy 55,223 17.99 993,461
2009-09-10 Schimmel Paul (Director) Sale 15,600 22.26 347,287
2009-09-09 Schimmel Paul (Director) Sale 30,000 22.10 662,940
2009-09-04 Schimmel Paul (Director) Sale 29,400 22.02 647,476
2009-06-18 Maraganore John (CEO) Sale 40,000 21.37 854,640
2009-06-18 Maraganore John (CEO) Option Ex 40,000 .48 19,000
2009-06-17 Maraganore John (CEO) Sale 40,000 21.40 855,840
2009-06-17 Maraganore John (CEO) Option Ex 40,000 .48 19,000
2009-06-16 Maraganore John (CEO) Sale 40,000 21.80 871,800
2009-06-16 Maraganore John (CEO) Option Ex 40,000 .48 19,000
2009-05-06 Novartis Pharma Ag (10% Owner) Buy 65,922 17.50 1,153,635
2009-04-22 Allen Patricia L (VP of Finance/Treasurer) Sale 25,000 17.63 440,725
2009-04-22 Allen Patricia L (VP of Finance/Treasurer) Option Ex 25,000 .95 23,750
2008-08-18 Maraganore John (CEO) Option Ex 750 .48 356
2008-08-14 Maraganore John (CEO) Sale 37,500 34.23 1,283,512
2008-08-14 Maraganore John (CEO) Option Ex 37,500 .48 17,812
2008-08-13 Greene Barry E (President and COO) Sale 35,440 33.93 1,202,372
2008-08-13 Greene Barry E (President and COO) Option Ex 30,889 .95 29,344
2008-08-13 Maraganore John (CEO) Sale 37,500 33.95 1,272,975
2008-08-13 Maraganore John (CEO) Option Ex 37,500 .48 17,812
2008-06-30 Maraganore John (CEO) Option Ex 3,000 .48 1,425
2008-05-08 Novartis Pharma Ag (10% Owner) Buy 213,888 25.29 5,409,227
2007-12-04 Schimmel Paul (Director) Sale 7,192 31.89 229,352
2007-12-03 Schimmel Paul (Director) Sale 11,586 32.63 378,074
2007-11-30 Schimmel Paul (Director) Sale 37,222 33.45 1,245,187
2007-11-30 Schimmel Paul (Director) Option Ex 20,000 10.91 218,200
2007-10-25 Allen Patricia L (VP of Finance/Treasurer) Sale 20,000 32.02 639,106
2007-10-25 Allen Patricia L (VP of Finance/Treasurer) Option Ex 20,000 .95 19,000
2007-10-24 Greene Barry E (COO) Sale 37,500 31.09 1,162,692
2007-06-29 Maraganore John (CEO) Sale 37,500 15.82 586,162
2007-06-29 Maraganore John (CEO) Option Ex 37,500 .48 17,812
2007-06-28 Maraganore John (CEO) Sale 37,500 16.01 600,276
2007-06-28 Maraganore John (CEO) Option Ex 37,500 .48 17,812
2006-10-31 Greene Barry E (COO and Treasurer) Sale 12,500 20.71 258,875
2006-05-16 Maraganore John (President & CEO) Sale 1,000 15.05 15,050
2006-05-15 Maraganore John (President & CEO) Sale 41,635 15.08 627,647
2006-05-15 Maraganore John (President & CEO) Option Ex 37,500 .48 17,812
2006-05-12 Maraganore John (President & CEO) Sale 41,635 15.46 639,695
2006-05-12 Maraganore John (President & CEO) Option Ex 37,500 .48 17,812
2006-03-07 Barrett Peter (Director) Sale 21,800 16.50 359,809
2006-03-06 Barrett Peter (Director) Sale 63,200 17.20 1,086,913
2006-03-03 Barrett Peter (Director) Sale 178,782 16.89 3,018,912
2006-03-02 Barrett Peter (Director) Sale 61,900 16.06 994,361
2006-03-01 Barrett Peter (Director) Sale 75,200 16.06 1,207,411
2006-02-28 Barrett Peter (Director) Sale 91,549 15.98 1,463,319
2006-02-27 Barrett Peter (Director) Sale 250,000 15.77 3,942,750
2006-02-24 Atlas Venture Associates Vi, L.p. (10% Owner) Sale 120,000 14.80 1,775,640
2006-02-24 Barrett Peter (Director) Sale 60,000 14.80 887,820
2006-02-23 Atlas Venture Associates Vi, L.p. (10% Owner) Sale 63,000 15.14 953,883
2006-02-23 Barrett Peter (Director) Sale 31,500 15.14 476,941
2006-01-31 Schimmel Paul (Director) Buy 100,000 13.00 1,300,000
2004-05-27 Abingworth Management Ltd (10% Owner) Buy 130,520 6.00 783,120

Insider trading activities including stock purchases, stock sales, and option exercises of ALNY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alnylam Pharmaceuticals, Inc. (symbol ALNY, CIK number 1178670) see the Securities and Exchange Commission (SEC) website.